An Open-Label, Single-Dose, 4-Way Crossover, Bioavailability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Food Effect of BBI-5000 Capsules in Healthy Adult Subjects

Trial Profile

An Open-Label, Single-Dose, 4-Way Crossover, Bioavailability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Food Effect of BBI-5000 Capsules in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Dec 2015

At a glance

  • Drugs BBI 5000 (Primary)
  • Indications Atopic dermatitis
  • Focus Pharmacokinetics
  • Sponsors Brickell Biotech
  • Most Recent Events

    • 01 Dec 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 28 Oct 2015 Status changed from planning to recruiting, as reported by ClinicalTrials.gov.
    • 11 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top